Durabolin 100 AMPULES - Canada Peptides

First detailed in 1957 and marketed soon after by Organon, nandrolone phenylpropionate (Durabolin) emerged as a key advancement in steroid-based therapy. Its shorter ester produced rapid effects, making it attractive for treating acute catabolic conditions. The compound was notably prescribed for both male and female patients, especially in Europe, where its use extended into the 1980s. While overshadowed by nandrolone decanoate, Durabolin continued to see use in select medical and performance settings worldwide.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Durabolin 100 AMPULES by Canada Peptides, consult with your doctor or healthcare professional.